LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
This Quarter Return
+3.22%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$3.6B
AUM Growth
+$3.6B
(+29%)
Cap. Flow
+$751M
Cap. Flow
% of AUM
20.87%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
467
New
156
Increased
40
Reduced
28
Closed
91
Top Buys
| 1 |
Apple
AAPL
|
$109M |
| 2 |
CVS Health
CVS
|
$96M |
| 3 |
Adobe
ADBE
|
$90.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$70.7M |
| 5 |
Microsoft
MSFT
|
$69.4M |
Top Sells
| 1 |
Kenvue
KVUE
|
$156M |
| 2 |
Vistra
VST
|
$144M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$121M |
| 4 |
General Motors
GM
|
$85M |
| 5 |
Honeywell
HON
|
$72.5M |
Sector Composition
| 1 | Healthcare | 38.37% |
| 2 | Technology | 18.29% |
| 3 | Consumer Discretionary | 9.42% |
| 4 | Financials | 7.94% |
| 5 | Energy | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
CSX Corp
CSX
$60.2B
| $17.6M | 0.15% |
+475,000
| New | +$17.6M |
|
52
Palo Alto Networks
PANW
$128B
| $17.6M | 0.15% |
+123,662
| New | +$17.6M |
|
53
Cencora
COR
$57.2B
| $17.3M | 0.15% |
+71,326
| New | +$17.3M |
|
54
Cleveland-Cliffs
CLF
$5.18B
| $17.1M | 0.14% |
+750,000
| New | +$17.1M |
|
55
Mineralys Therapeutics
MLYS
$1.94B
| $16.8M | 0.14% |
1,304,216
+148,148
| +13% | +$1.91M |
|
56
Pyxis Oncology
PYXS
$91.2M
| $16.4M | 0.14% |
3,861,179
+690,376
| +22% | +$2.94M |
|
|
MRO
57
DELISTED
Marathon Oil Corporation
MRO
| $15.6M | 0.13% |
+549,857
| New | +$15.6M |
|
58
First Horizon
FHN
$11.4B
| $15.4M | 0.13% |
1,000,000
+963,839
| +2,665% | +$14.8M |
|
59
Expedia Group
EXPE
$26.3B
| $14.8M | 0.13% |
+107,243
| New | +$14.8M |
|
60
eBay
EBAY
$41.2B
| $14.6M | 0.12% |
276,322
+248,797
| +904% | +$13.1M |
|
61
Old Dominion Freight Line
ODFL
$31.1B
| $14.6M | 0.12% |
+66,410
| New | +$14.6M |
|
62
Paycom
PAYC
$12.5B
| $14.4M | 0.12% |
+72,545
| New | +$14.4M |
|
63
Moody's
MCO
$89B
| $14.4M | 0.12% |
+36,644
| New | +$14.4M |
|
|
VRNA
64
Verona Pharma
VRNA
$9.18B
| $14.2M | 0.12% |
882,040
+298,582
| +51% | +$4.8M |
|
65
TD Synnex
SNX
$12.2B
| $14.1M | 0.12% |
+125,000
| New | +$14.1M |
|
66
Pultegroup
PHM
$26.3B
| $13.9M | 0.12% |
+115,185
| New | +$13.9M |
|
67
Praxis Precision Medicines
PRAX
$980M
| $13.7M | 0.12% |
+225,000
| New | +$13.7M |
|
|
AUTL
68
Autolus Therapeutics
AUTL
$383M
| $13.3M | 0.11% |
2,090,471
+1,205,000
| +136% | +$7.69M |
|
69
MGM Resorts International
MGM
$10.4B
| $13.3M | 0.11% |
+280,800
| New | +$13.3M |
|
70
EyePoint Pharmaceuticals
EYPT
$827M
| $13M | 0.11% |
629,396
-4,013
| -0.6% | -$82.9K |
|
71
Lennar Class A
LEN
$34.7B
| $12.8M | 0.11% |
+77,112
| New | +$12.8M |
|
72
Idexx Laboratories
IDXX
$50.7B
| $12.6M | 0.11% |
+23,263
| New | +$12.6M |
|
73
PepGen
PEPG
$39M
| $12.4M | 0.1% |
841,431
+176,915
| +27% | +$2.6M |
|
74
Solid Biosciences
SLDB
$448M
| $12.4M | 0.1% |
928,169
| – | – |
|
75
Cardinal Health
CAH
$36B
| $12.3M | 0.1% |
+110,017
| New | +$12.3M |
|